Meanwhile, we found that the RSRC2 expression was lower in the chemotherapy non-responder than in the chemotherapy responder (Figure 3G) by using the Kaplan–Meier Plotter, suggesting that breast cancer with RSRC2 low expression was prone to drug resistance than RSRC2 high expression. This evidence concerns the gene RSRC2 and breast cancer.